drugset / Trial / NCT00947245
Japanese Bridging Study Conducted in the United States
RandomizedParallel-groupTriple-blind
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics following single oral and multiple oral doses BMS-791325 in healthy Japanese subjects.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclabuvir | Small molecule | 300 mg | Oral |
| Subject | Beclabuvir | Small molecule | 900 mg | Oral |
| Subject | Beclabuvir | Small molecule | 1200 mg | Oral |